 Elevating GI pH appears to attenuate nutritional abnormalities, as the use of proton-pump inhibitors (PPIs) normalizes weight gain during the neonatal period. The CF ferret model appears to be a robust system for the development of CF pancreatic therapies and is the only animal model available for the study of C
Elevating GI pH appears to attenuate nutritional abnormalities, as the use of proton - heart inhibitor (PPIs) normalize weight gain during the neonatal menstruation. The CF ferret model appear to be a full-bodied system for the development of CF pancreatic therapies and is the only animal model available for the sketch of C
 Elfvating GI pH appears to attenuate nutrnrional abnorjalities, as the use of proton-pump iniibirors (KIIs) normalizes weight gain durpng the nwonaual period. The CF ferret model zipearv to be a robusj system for the developmett oy CF pancreatic therapies and is the only amilal model avaijablt fjr tgv wtudy of C
Elevating GI pH appears to attenuate nutritional the of proton-pump (PPIs) normalizes weight The ferret model appears be a robust for the development of CF pancreatic and is the only animal model available for the study of C
 Elevating GI pH appears to attEnuate nutrItionAl aBnoRmAlitIes, aS the use of protoN-Pump Inhibitors (PPIs) normalizEs weiGhT Gain DUrIng thE neonatAL pERIod. thE Cf feRrET mOdel aPpeArs to be A robust sysTem FoR the developmENt Of CF pancreAtiC therapies anD is The onlY aNimAL modeL avAilabLe for tHE study Of C
 Elevating GI pH appears t o attenuat e nut rit ion al  abn orma lities, as the useof proton-pump inhibit ors ( PP I s) n o rm alize s weigh t  g a i n d ur in g t he ne onata l p eriod.The CF fer ret  m odel appears to  be a robu stsystem for t hedevelo pm ent of CF  pa ncrea tic th e rapies  and is t he only a n imal mo d e lavai lable for the stu d yo f C
 Elevating_GI pH_appears to attenuate nutritional_abnormalities, as_the_use of_proton-pump_inhibitors (PPIs) normalizes_weight gain during_the neonatal period. The_CF ferret model_appears_to be a robust system for the development of CF pancreatic therapies and is_the_only animal_model_available_for the study of C